
    
      A consecutive cohort of resected HCC patients will be analyzed. Several different prognostic
      factors, including FLNA expression, will be tested against the risk of ER. FLNA expression
      will be analyzed with immunohistochemistry in the intra-tumoral and extra-tumoral tissue
      compartments using a dedicated tissue microarray.
    
  